Mirae Asset Global Investments’s Alpine Immune Sciences Inc ALPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-14,430
Closed -$397K 2673
2024
Q1
$397K Sell
14,430
-5,747
-28% -$170K ﹤0.01% 2003
2023
Q4
$385K Buy
20,177
+3,024
+18% +$42K ﹤0.01% 2090
2023
Q3
$196K Buy
17,153
+72
+0.4% +$886 ﹤0.01% 2306
2023
Q2
$176K Buy
+17,081
New +$154K ﹤0.01% 2382

Mirae Asset Global Investments's ALPN Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 14,430 shares — an estimated $397K sold.

Mirae Asset Global Investments first reported a position in ALPN in Q2 2023 and held it in 4 quarters. The position peaked at $397K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 14,430 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $397K.
  • Mirae Asset Global Investments first reported a position in Alpine Immune Sciences Inc in Q2 2023 and held it in 4 quarters.
  • Mirae Asset Global Investments's Alpine Immune Sciences Inc position peaked at $397K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.